About TREAT Asia
TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) is a collaborative network of clinics, hospitals, research institutions, and civil society that is working to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through research, education, and advocacy of evidence-based HIV-related policies. TREAT Asia’s unique capacity to bring together researchers, doctors, activists, advocates, and policymakers plays an important role in the region’s response to HIV, and it has become a model for regional collaboration on HIV/AIDS.
The Asia-Pacific region is home to over 60% of the world’s population and more HIV-positive people than any region outside sub-Saharan Africa. When TREAT Asia was founded in 2001, little attention was being paid to the looming AIDS crisis in the region. Substantial progress has since been made to develop comprehensive local, national, and regional responses to combat HIV, and the number of new infections in the region has decreased by approximately 10% and AIDS-related deaths by nearly 40% since 2005.
However, many challenges to turning the tide against AIDS in the Asia-Pacific remain. Only one-third of HIV-positive people in the region currently have access to antiretroviral therapy (ART). In addition, HIV-positive pregnant women in South Asia have the world’s lowest rate of access to the antiretroviral medicines needed to prevent mother-to-child transmission of HIV.
While the region has seen an overall decline in new infections, in several countries—including China, Indonesia, Pakistan, and the Philippines—rates of new infections are increasing. In Indonesia and Pakistan, AIDS-related deaths have quadrupled since 2005. Also, HIV rates among key populations—people who inject drugs (PWID), men who have sex with men (MSM), transgender individuals, and sex workers—are far higher than among the general population, and rising.